Feng Yang
Research Subjects
Research Interests
Feng Yang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chaoli Wang
Department of Pharmaceutical Analysis, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China
1 shared publication - Hao Gao
Tangdu Hospital, Air Force Medical University, Xi’an 710032, P. R. China
1 shared publication - Kai Su
Department of Thoracic Surgery, General Hospital of Southern Theater Command, PLA, No. 111, Liuhua Road, Guangzhou 510010, P. R. China
1 shared publication - Peng Chen
Surgery Department, 96601 Army Hospital, PLA, Huangshan, Anhui 245000, P. R. China
1 shared publication - Youbei Qiao
Department of Medicinal Chemistry and Pharmaceutical Analysis, School of Pharmacy, Fourth Military Medical University, Xi'an, China
1 shared publication - Yuan Zhai
Basic Medical College, Fourth Military Medical University, Xi'an 710032, China
1 shared publication
Latest Publications
- 30 December 2023
- Published by World Scientific Pub Co Pte Ltd in Nano
- Vol. 18 (14)
Ionic Liquids Nanoliposomes Based on Targeted and Active Permeability for Enhanced Combination Chemotherapy Efficiency
Tumor microenvironment severely restricts the delivery of chemotherapy drugs. The microenvironment responsive nanoparticles often have complex designs with hampered clinical translatability. Here, we show a kind of ionic liquids (ILs) with soybean lecithin (SL) as cation, folic acid (FA) as anion, in particular, it could formulate nanoliposome by film evaporation method to deliver cis-Diamineplatinum (II) dichloride (cisplatin, Cis) and doxorubicin hydrochloride (DOX). These special ILs liposome could target tumor cells via folate receptor-mediated endocytosis by enhancing the cellular uptake, and significantly improve the deep permeability by actively infiltrating throughout the tumor tissue owing to the special noncovalent bond between SL–FA ILs with cell membrane. Moreover, ILs liposomes improve delivery efficiency of Cis and DOX and enhance the combined chemotherapeutic effect. The simple preparation process of the ILs nanoliposome should facilitate the clinical transformation of nanodrugs.
- 30 December 2023
- Published by World Scientific Pub Co Pte Ltd in Nano
- Vol. 18 (14)
Ionic Liquids Nanoliposomes Based on Targeted and Active Permeability for Enhanced Combination Chemotherapy Efficiency
Tumor microenvironment severely restricts the delivery of chemotherapy drugs. The microenvironment responsive nanoparticles often have complex designs with hampered clinical translatability. Here, we show a kind of ionic liquids (ILs) with soybean lecithin (SL) as cation, folic acid (FA) as anion, in particular, it could formulate nanoliposome by film evaporation method to deliver cis-Diamineplatinum (II) dichloride (cisplatin, Cis) and doxorubicin hydrochloride (DOX). These special ILs liposome could target tumor cells via folate receptor-mediated endocytosis by enhancing the cellular uptake, and significantly improve the deep permeability by actively infiltrating throughout the tumor tissue owing to the special noncovalent bond between SL–FA ILs with cell membrane. Moreover, ILs liposomes improve delivery efficiency of Cis and DOX and enhance the combined chemotherapeutic effect. The simple preparation process of the ILs nanoliposome should facilitate the clinical transformation of nanodrugs.